These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension. Seedat YK, Vawda EI, Mitha S, Ramasar R. S Afr Med J; 1970 Mar 07; 44(10):300-1. PubMed ID: 5443298 [No Abstract] [Full Text] [Related]
4. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension. Amery A, Verstraete M, Bossaert H, Verstreken G. Br Med J; 1970 Nov 14; 4(5732):392-5. PubMed ID: 4921284 [Abstract] [Full Text] [Related]
5. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. A double-blind crossover study. Mroczek WJ, Leibel BA, Finnerty FA. Am J Cardiol; 1972 May 14; 29(5):712-7. PubMed ID: 4553738 [No Abstract] [Full Text] [Related]
6. Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect. Amery AK, Bossaert H, Fagard RH, Verstraete M. Acta Cardiol; 1972 May 14; 21(1):82-99. PubMed ID: 4553878 [No Abstract] [Full Text] [Related]
8. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension]. Ludwig H. Arzneimittelforschung; 1968 May 14; 18(5):600-4. PubMed ID: 5755891 [No Abstract] [Full Text] [Related]
10. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients. Sung PK, Samet P, Yeh BK. Curr Ther Res Clin Exp; 1971 May 14; 13(5):280-5. PubMed ID: 4998390 [No Abstract] [Full Text] [Related]
11. [Controllable hypertension therapy with Tadip]. Schütz E. Med Klin; 1971 Jan 22; 66(4):121-6. PubMed ID: 5546736 [No Abstract] [Full Text] [Related]
12. A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension. Tuomilehto J, Puska P, Mustaniemi H. Acta Med Scand Suppl; 1974 Jan 22; 554():47-54. PubMed ID: 4593673 [No Abstract] [Full Text] [Related]
13. Methyldopa: single daily dose versus multiple daily dose. Yang C, Gurwich E, Kanada S, Nascimento L. Clin Ther; 1982 Jan 22; 4(5):395-401. PubMed ID: 7039841 [Abstract] [Full Text] [Related]
14. A comparative study of metoprolol and methyldopa in the treatment of hypertension. Karachalios GN. Int J Clin Pharmacol Ther Toxicol; 1983 Sep 22; 21(9):476-8. PubMed ID: 6629553 [Abstract] [Full Text] [Related]
15. Long-term treatment of hypertension with methyldopa. VIII. Overview. Itskovitz HD. J Cardiovasc Pharmacol; 1981 Sep 22; 3 Suppl 2():S120-7. PubMed ID: 6172668 [Abstract] [Full Text] [Related]
16. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)]. Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Solinas E, Toso M, Motolese M. G Ital Cardiol; 1980 Sep 22; 10(11):1482-90. PubMed ID: 7202896 [Abstract] [Full Text] [Related]
17. Comparative antihypertensive effects of guanabenz and methyldopa. Walker BR, Deitch MW, Schneider BE, Hare LE. Clin Ther; 1981 Sep 22; 4(4):275-84. PubMed ID: 7332915 [Abstract] [Full Text] [Related]
18. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647 [Abstract] [Full Text] [Related]